Impax Laboratories Inc. (IPXL) Jumps 7.43% on January 14

Equities Staff |

Impax Laboratories Inc. (IPXL) was among the biggest gainers on the Russell 2000 for Thursday January 14 as the stock popped 7.43% to $38.73, representing a gain of $2.68 per share. Some 416,402 shares traded hands on 4,016 trades, compared with an average daily volume of 848,979 shares out of a total float of 70.51 million. The stock opened at $36.44 and traded with an intraday range of $38.87 to $35.23.

After today's gains, Impax Laboratories Inc. reached a market cap of $2.73 billion. Impax Laboratories Inc. has had a trading range between $52.10 and $31.83 over the last year, and it had a 50-day SMA of $41.21 and a 200-day SMA of $43.96.

The stock has a P/E Ratio of 99.9.

Impax Laboratories Inc is a technology-based, specialty pharmaceutical company. It is engaged in the development and commercialization of bioequivalent and brand-name pharmaceuticals, utilizing its controlled-release and other in-house development.

Impax Laboratories Inc. is based out of Hayward, CA and has some 1,061 employees. Its CEO is G. Frederick Wilkinson.

For a complete fundamental analysis analysis of Impax Laboratories Inc., check out Equities.com’s Stock Valuation Analysis report for IPXL. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Star Navigation Systems Group Ltd.

Star Navigation Systems Group Ltd is engaged in the development, marketing and promotion of in-flight safety monitoring systems.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

D-Wave

D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…